The diarrheic attaching and effacing (A/E) pathogenEscherichia albertiiwas first isolated from infants in Bangladesh in 1991, although the bacterium was initially classified asHafnia alvei. Subsequent genetic and biochemical interrogation of these isolates raised concerns about their initial taxonomic placement. It was not until 2003 that these isolates were reassigned to the novel taxonEscherichia albertiibecause they were genetically more closely related toE. coli, although they had diverged sufficiently to warrant a novel species name. Unfortunately, new isolates continue to be mistyped as enteropathogenicE. coli(EPEC) or enterohemorrhagicE. coli(EHEC) owing to shared traits, most notably the ability to form A/E lesions. Consequently,E. albertiiremains an underappreciated A/E pathogen, despite multiple reports demonstrating that many provisional EPEC and EHEC isolates incriminated in disease outbreaks are actuallyE. albertii. Metagenomic studies on dozens ofE. albertiiisolates reveal a genetic architecture that boasts an arsenal of candidate virulence factors to rival that of its better-characterized cousins, EPEC and EHEC. Beyond these computational comparisons, studies addressing the regulation, structure, function, and mechanism of action of its repertoire of virulence factors are lacking. Thus, the paucity of knowledge about the epidemiology, virulence, and antibiotic resistance ofE. albertii, coupled with its misclassification and its ability to develop multidrug resistance in a single step, highlights the challenges in combating this emerging pathogen. This review seeks to synthesize our current but incomplete understanding of the biology ofE. albertii.